RAPT Therapeutics, Inc.RAPT Therapeutics, Inc.RAPT Therapeutics, Inc.

RAPT Therapeutics, Inc.

No trades
See on Supercharts

Price target

64.130.000.00%
The 8 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.

Analyst rating

Based on 10 analysts giving stock ratings in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


RAPT EPS for the last quarter is −0.65 USD despite the estimation of −0.98 USD. In the next quarter EPS is expected to reach −0.77 USD. Track more of RAPT Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter RAPT Therapeutics, Inc. revenue is expected to reach 0.00 USD. Check out RAPT Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, RAPT price target is 64.13 USD with a max estimate of 72.00 USD and a min estimate of 55.00 USD. Check if this forecast comes true in a year, meanwhile watch RAPT Therapeutics, Inc. stock price chart and keep track of the current situation with RAPT news and stock market news.
We've gathered opinions of 10 analysts rating RAPT stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.